SCHEMBL926071

SCHEMBL926071

CC(C)(C)c1ccc(S(=O)(=O)N2c3ccccc3C[C@H]2C(=O)NCCc2c(Cl)cccc2Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.46
EPHX2 P34913 2/20 0.41
RORC P51449 1/20 0.41
PSEN1 P49768 2/20 0.40
PSEN2 P49810 2/20 0.40
APH1B Q8WW43 2/20 0.40
NCSTN Q92542 2/20 0.40
APH1A Q96BI3 2/20 0.40
PSENEN Q9NZ42 2/20 0.40
LMNA P02545 2/20 0.40
PTGER3 P43115 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GLA P06280 1/20 0.40
PKM P14618 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPK1 P28482 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL926976 0.91 HSD11B1 (0.46) HSD11B1EPHX2RORCPSEN1PSEN2
SCHEMBL927527 0.88 FKBP1A (0.48) RORCPSEN1PSEN2APH1BNCSTN
SCHEMBL928733 0.88 PSEN1 (0.51) HSD11B1PSEN1PSEN2APH1BNCSTN
SCHEMBL926338 0.87 FKBP1A (0.49) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL926670 0.87 BDKRB1 (0.44) HSD11B1EPHX2RORCPSEN1PSEN2
SCHEMBL926724 0.87 PSEN1 (0.46) EPHX2RORCPSEN1PSEN2APH1B
SCHEMBL927221 0.86 EPHX2 (0.52) HSD11B1EPHX2RORCPSEN1PSEN2
SCHEMBL926686 0.85 ESRRG (0.47) RORCPSEN1PSEN2APH1BNCSTN
SCHEMBL926912 0.85 FKBP1A (0.54) RORCPSEN1PSEN2APH1BNCSTN
SCHEMBL927595 0.85 POLB (0.51) LMNAALDH1A1MAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872021-B2 LXR receptor modulators LABORATORIES FOURNIER S.A. (FR) 2011-01-18 US disclosed
US-20070099960-A1 LXR receptor modulators LABORATOIRES FOURNIER S.A. (FR) 2007-05-03 US disclosed
EP-1742918-A1 LXR RECEPTOR MODULATORS LABORATOIRES FOURNIER S.A. (FR) 2007-01-17 EP disclosed
WO-2005121093-A1 LXR RECEPTOR MODULATORS LABORATOIRES FOURNIER S.A. (FR) 2005-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099960-A1 LXR receptor modulators NR1H2, NR1H3, PPARD HSD11B1 78/4885EPHX2 3088/4885RORC 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.